Skip to main content
TipRanks
Go Ultimate75% OFF

Harmony Biosciences Holdings (HRMY) Income Statement

460 Followers

Harmony Biosciences Holdings Income Statement

Last quarter (Q3 2026), Harmony Biosciences Holdings's total revenue was $268.92M, an increase of 12.30% from the same quarter last year. In Q3, Harmony Biosciences Holdings's net income was $48.20M. See Harmony Biosciences Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 868.45M$ 714.73M$ 582.02M$ 437.86M$ 305.44M
$ 670.11M$ 557.92M$ 460.79M$ 354.37M$ 249.92M
$ 461.64M$ 367.09M$ 268.76M$ 234.19M$ 162.39M
Depreciation and Amortization$ 25.34M$ 24.11M$ 24.36M$ 23.39M$ 18.84M
$ 255.05M$ 233.41M$ 221.51M$ 146.87M$ 80.46M
$ 208.47M$ 190.83M$ 192.03M$ 120.19M$ 87.53M
$ 6.59M$ 978.00K$ -18.63M$ -15.50M$ -50.10M
$ 215.06M$ 191.80M$ 173.40M$ 104.69M$ 37.43M
$ 158.69M$ 145.49M$ 128.85M$ 181.47M$ 34.60M
Per Share Metrics
Basic EPS$ 2.76$ 2.56$ 2.17$ 3.07$ 0.60
Diluted EPS$ 2.71$ 2.51$ 2.13$ 2.97$ 0.58
Weighted Average Shares Outstanding57.49M56.88M59.47M59.17M57.53M
Weighted Average Shares Outstanding (Diluted)58.54M57.87M60.37M61.10M59.21M

Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

-500M0500M1B-3000 %-1500 %0 %1500 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin